MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilien, B.
Right arrow Articles by Laduron, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilien, B.
Right arrow Articles by Laduron, P. M.

Characterization of solubilized serotonin (S2) receptors in rat brain

B Ilien, H Gorissen and PM Laduron

[3H]Spiperone binding sites were solubilized from rat frontal cortex and striatum by means of the mild detergent, lysolecithin. In the frontal cortex, the binding sites were extracted from a microsomal membrane fraction which was found to be enriched in serotonin (S2) receptors when labeled either with [3H]spiperone or with [3H]lysergic acid diethylamide. Although the extraction yield was relatively low, the [3H]spiperone binding sites solubilized from the frontal cortex retained the high-affinity characteristics of serotonin (S2) receptors in the original membrane: low KD (1.4 nM); binding saturable, reversible, and stereospecific; and displaying a high affinity toward the most potent serotonin antagonists (pirenperone, pipamperone, ketanserin, methysergide, and mianserin). There was a very good correlation between the drug potencies in both soluble and membrane preparations. The molecular dispersion of the soluble extract was assessed by several criteria, including a low sedimentation coefficient in sucrose gradient. No specific binding sites could be extracted from the cerebellum. In contrast, few binding sites endowed with the characteristics of serotonin (S2) receptors were detected in lysolecithin extracts from rat striatum. However, the S2 sites became more apparent when a tetralin derivative was added to the incubation medium in order to prevent [3H]spiperone binding on solubilized dopamine receptors. In contrast, when microsomal membranes from rat striatum were treated with digitonin, the solubilized [3H]spiperone binding sites were only of a dopaminergic nature.

Volume 22, Issue 2, pp. 243-249, 09/01/1982
Copyright © 1982 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1982 by the American Society for Pharmacology and Experimental Therapeutics